Assistant Professor, Medicine, University of Maryland School of Medicine
Nephrology
Dr. Stephen L. Seliger, MD
|
|
Give Review
Stephen Seliger works in the field of Nephrology. He graduated from NYU School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Stephen L. Seliger is also a published doctor. He has 99 paper published. The most recent paper is: Visual evoked potential assessment of the effects of glaucoma on visual subsystems. He accepts Medicare.
Publications
- Risk for cognitive impairment across 22 measures of cognitive ability in early-stage chronic Kidney disease.
- Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS).
- Frailty and Cognitive Impairment in ESRD: Brain-Body Connections.
- Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults:A Metaanal...
- Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without Acute myocardial infarction.
- NT-proBNP and troponin T and risk of rapid Kidney function decline and incident CKD in elderly adults.
- Association Between Chronic Kidney Disease Progression and Cardiovascular Disease: Results from the CRIC Study.
- Periodontal Disease, Renal Dysfunction and Heightened Leukocytosis.
- Complete inhibition of the rennin-angiotensin-aldosterone system; where do we stand?
- A Pilot Study to Evaluate Renal Hemodynamics in Cirrhosis by Simultaneous Glomerular Filtration Rate, Renal Plasma Flow, Renal Resistive Indices and Biomarkers Measure...
- Cognitive and physical function in chronic Kidney disease.
- Serum potassium in dual Renin-Angiotensin-aldosterone system blockade.
- Age and Sex Dependent Upper Reference Limits for the High Sensitivity Cardiac Troponin T Assay.
- High-sensitive cardiac troponin assays: more information, more challenges.
- Interpreting cardiac troponin results from highly sensitive assays in patients with chronic kidney disease: Acute coronary syndromes and beyond.
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy.
- Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart Failure in community-dwelling old...
- Decline in renal functioning is associated With longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory.
- Performance of chronic Kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating Kidney function in cirrhosis.
- Association between Physical Performance and All-Cause Mortality in CKD.
- Judgment of Line Orientation: An examination of eight short forms.
- Cognitive impairment in dialysis patients: focus on the blood vessels?
- Retinopathy and Cognitive Impairment in Adults With CKD.
- Amino Terminal Pro-B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy.
- Biomarkers of Chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
- Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
- Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart Failure risk in older adults.
- Physical Activity in ESRD: Time to Get Moving.
- Cardiac Micro-Injury Measured by Troponin T Predicts Collagen Metabolism in Adults Aged >= 65 Years with Heart Failure.
- A Varying Patient Safety Profile Between Black and Nonblack Adults With Decreased Estimated GFR.
- Left ventricular ejection fraction assessment in older adults an adjunct to natriuretic Peptide testing to identify risk of new-onset heart Failure and cardiovascular ...
- Longitudinal association of depressive symptoms with rapid Kidney function decline and adverse clinical renal disease outcomes.
- Erythropoiesis-stimulating agents increase the risk of Acute stroke in patients with chronic kidney disease.
- Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart Failure and mortality.
- Vascular risk factors and cognitive impairment in chronic Kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study.
- Association of serial measures of cardiac troponin T using a sensitive assay with incident heart Failure and cardiovascular mortality in older adults.
- Gender disparity in liver transplant waiting-list mortality: the importance of Kidney function.
- Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart Failure and prediction o...
- Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
- Adverse safety events in chronic Kidney disease: the frequency of "multiple hits".
- Comorbidity and confounding in end-stage renal Disease.
- Nonsteroidal anti-inflammatory drugs, aspirin, and cognitive function in the Baltimore longitudinal study of aging.
- Stroke in ESRD: the other cardiovascular Disease.
- Biomarkers for prognostication after Acute coronary syndromes: new times and statistics.
- The frequency of hyperkalemia and its significance in chronic Kidney disease.
- Frequency of hypoglycemia and its significance in chronic Kidney disease.
- CKD as an underrecognized threat to patient safety.
- Association of serum phosphate With vascular and valvular calcification in moderate CKD.
- Chronic Kidney disease adversely influences patient safety.
- Cystatin C concentration as a predictor of systolic and diastolic heart Failure.
- Lessons about brain vascular disease from another pulsating organ, the Kidney.
- Lipoprotein abnormalities associated with mild impairment of Kidney function in the multi-ethnic study of atherosclerosis.
- The relationship between dialysis performance measures: adequacy and anemia management.
- Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart Failure and predicting mortality.
- Subclinical vascular Disease of the brain in dialysis patients.
- Center effects in anemia management of dialysis patients.
- Cystatin C and prognosis for cardiovascular and Kidney outcomes in elderly persons without chronic Kidney disease.
- Cystatin C and incident peripheral arterial Disease events in the elderly: results from the Cardiovascular Health Study.
- Cystatin C and subclinical brain infarction.
- Cystatin C and the risk of death and cardiovascular events among elderly persons.
- A rare cause of necrotizing and crescentic Glomerulonephritis in a young adult male.
- Serum phosphate levels and mortality risk among people with chronic Kidney disease.
- Survival following parathyroidectomy among United States dialysis patients.
- Moderate Renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study.
- Parathyroidectomy rates among United States dialysis patients: 1990-1999.
- Cardiovascular and thromboembolic events following Hypertensive pregnancy.
- Risk factors for upper gastrointestinal bleeding among end-stage renal Disease patients.
- Risk factors for incident stroke among patients with end-stage renal Disease.
- Elevated risk of stroke among patients with end-stage renal Disease.
- Are HMG-CoA reductase inhibitors underutilized in dialysis patients?
- HMG-CoA reductase inhibitors are associated With reduced mortality in ESRD patients.
- Albuminuria and the risk of incident stroke and stroke types in older adults.
- Visual evoked potential assessment of the effects of glaucoma on visual subsystems.
- Racial and ethnic differences in incident myocardial infarction in end-stage renal Disease patients: The USRDS.
- Inflammation and dyslipidemia in Nephropathy: an epidemiologic perspective.
- Gender and the progression of renal Disease.
- Simultaneous liver-Kidney versus liver transplantation alone in patients with end-stage liver disease and Kidney dysfunction not on dialysis.
- Chronic Kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study.
- Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study.
- Chronic Kidney disease and the risk of end-stage renal disease versus death.
- Kidney function predicts the rate of bone loss in older individuals: the Cardiovascular Health Study.
- Initiation of anaemia management in patients with chronic Kidney disease not on dialysis in the Veterans Health Administration.
- Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic Nephropathy (VA NEPHRON-D).
- Cardiovascular risk factors and incident Acute renal failure in older adults: the cardiovascular health study.
- Cystatin C and aging success.
- Association of Kidney function with incident hip fracture in older adults.
- Kidney function, electrocardiographic findings, and cardiovascular events among older adults.
- Prognosis in proliferative lupus Nephritis: the role of socio-economic status and race/ethnicity.
- Inflammatory and prothrombotic markers and the progression of renal Disease in elderly individuals.
- Racial variations in erythropoietic response to epoetin alfa in chronic Kidney disease and the impact of smoking.
- Mild elevations of urine albumin excretion are associated With atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA).
- Cigarette smoking and incident chronic Kidney disease: a systematic review.
- Renal function and cardiovascular response to mental stress.
- A single center comparison of long-term outcomes of Renal allografts procured laparoscopically versus historic controls procured by the open approach.
- Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 Diabetes.
- Chronic Kidney disease, creatinine and cognitive functioning.
- Nephrogenic systemic fibrosis and Diabetes mellitus.
- Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic Kidney disease.
Schools
New York University School Of Medicine
Columbia University Med Center
University of Washington
Conditions Treated
- Acute Kidney Failure
- Chronic GlomeruloNephritis
- Chronic Kidney Diseases
- Congenital Cystic Kidney Disease
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Washington -
New York Presbyterian Hospital -
NYU School of Medicine
Hospital
-
University of Maryland Medical Center
Drug Facts
| NPI NUMBER | 1447290671 | |
| NPPES Provider LastName | SELIGER | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 212011544 | |
| NPPES Provider State | MD | |
| Specialty Description | Nephrology | |
| Total Claim Count | 48.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447290671 |
| Last Name Of The Provider | SELIGER |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
|
Dr. Mohamed G. Atta, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asha N. Sasimangalam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia J. Scialla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Radcliffe M. Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdolreza Haririan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rohini Adhikarla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Choi, MD
This Doctor is OpenDoctor Recommended.
|